Haemophilia A is a hereditary bleeding disorder, which has been considered rare and chronic. The burden of this disease in Portugal remains unknown. The aim of this study was to estimate the annualized cost and health burden of haemophilia A in Portugal.Financial support for the study was provided by Roche. Eurotrials, Scientific Consultants (Contract Research Organization) was appointed by Roche to conduct the independent expert panel and perform the economic analysis
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies against coagulatio...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Copyright © 2014 Published by Elsevier Inc.Hypercholesterolemia is a risk factor for ciculatory dise...
Haemophilia A is a hereditary bleeding disorder, which has been considered rare and chronic. The bur...
Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous injections o...
Background : Haemophilia is a rare hereditary haemorrhagic disease requiring regular intravenous inj...
Introduction and Objectives: Haemophilia is a rare hereditary haemorrhagic disease that requires reg...
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease ...
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelon...
This paper is an attempt to enrich the literature about the role that can play some economic approac...
Abstract Background Severe haemophilia is associated with major psychological and economic burden fo...
Background: Determination of resource consumption is the basic information for health economic analy...
Adriana Aparecida Ferreira,1 Isabel Cristina Gonçalves Leite,2 Maria Teresa Bustamante-Teixei...
Background: Blood disorders comprise a wide range of diseases including anaemia, malignant blood dis...
Haemophilia is a rare disease. To improve knowledge, prospective studies of large numbers of subject...
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies against coagulatio...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Copyright © 2014 Published by Elsevier Inc.Hypercholesterolemia is a risk factor for ciculatory dise...
Haemophilia A is a hereditary bleeding disorder, which has been considered rare and chronic. The bur...
Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous injections o...
Background : Haemophilia is a rare hereditary haemorrhagic disease requiring regular intravenous inj...
Introduction and Objectives: Haemophilia is a rare hereditary haemorrhagic disease that requires reg...
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease ...
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelon...
This paper is an attempt to enrich the literature about the role that can play some economic approac...
Abstract Background Severe haemophilia is associated with major psychological and economic burden fo...
Background: Determination of resource consumption is the basic information for health economic analy...
Adriana Aparecida Ferreira,1 Isabel Cristina Gonçalves Leite,2 Maria Teresa Bustamante-Teixei...
Background: Blood disorders comprise a wide range of diseases including anaemia, malignant blood dis...
Haemophilia is a rare disease. To improve knowledge, prospective studies of large numbers of subject...
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies against coagulatio...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Copyright © 2014 Published by Elsevier Inc.Hypercholesterolemia is a risk factor for ciculatory dise...